newsfilter
← Latest News
PR Newswire·

INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Fractyl Health, Inc. to Contact Law Firm

  • Fractyl Health announced six-month REMAIN-1 Midpoint Cohort data on January 29, 2026, showing 4.5% weight regain for Revita patients versus 7.5% for the sham group, while noting the cohort lacked sufficient power for efficacy analysis.
  • Management disclosed that one study site contributed higher-than-expected weight regain across both groups, attributing the variability to a less robust diet & lifestyle counseling program.
  • Fractyl stock fell 68.03% ($1.245) to close at $0.585 on January 29, 2026, following the announcement.
  • Morgan Stanley downgraded the stock & reduced its price target from $8.00 to $2.00, while Canaccord Genuity reported on the counseling program issue.
  • Fractyl stock declined an additional 21.37% ($0.125) to close at $0.46 on January 30, 2026.
  • Fletcher Moore of Moore Law PLLC is seeking monetary damages, governance reforms, & reimbursement for Fractyl Health shareholders via a contingency fee arrangement.
  • Shareholders are advised to contact fletcher@fmoorelaw.com to pursue potential claims at no cost.